TY  - JOUR
AU  - Yoshihara, Shota
AU  - Takahashi, Kayoko
AU  - Kawaguchi, Hiroyuki
AU  - Harai, Nozomi
AU  - Tsuchiya, Kyoichiro
PY  - 2025
DA  - 2025/5/20
TI  - Effects of Using a Digital Peer-Supported App on Glycated Hemoglobin Changes Among Patients With Type 2 Diabetes: Prospective Single-Arm Pilot Study
JO  - JMIR Form Res
SP  - e72659
VL  - 9
KW  - diabetes type 2
KW  - T2DM
KW  - self-management
KW  - digital health
KW  - HbA1c
KW  - lifestyle intervention
KW  - digital intervention
KW  - type 2 diabetes mellitus
KW  - glycated hemoglobin
AB  - Background: Controlling glycated hemoglobin (HbA1c) levels can be challenging for patients with type 2 diabetes mellitus (T2DM). Peer support promotes HbA1c control, and a digital peer-supported app designed for group interactions may enable patients with T2DM to encourage one another to achieve better HbA1c outcomes. However, no studies have investigated the use of digital peer-supported apps to control HbA1c levels in patients with T2DM. Objective: This pilot study aimed to explore the effects of a digital peer-supported app on HbA1c control in patients with T2DM. Methods: This prospective single-arm pilot study enrolled patients with T2DM who owned smartphones and visited medical institutions in Japan. During the 3-month intervention, participants used a digital peer-supported app in addition to receiving standard care. This app allowed participants to share activity logs and concerns via a chat function to improve HbA1c levels through mutual engagement and encouragement. The primary outcome was the change in HbA1c levels, measured at health care facilities at baseline and after 3 months. The secondary outcomes were body weight and blood pressure, with the most recent data obtained from hospitals and clinics. Physical activity (≥1 hour/day) was assessed at the same time points using a self-reported questionnaire. Results: The study included 21 participants with a median age of 56 (IQR 51‐61) years, of which 13 (61.9%) were female. After using the digital peer-supported app for 3 months, the participants’ HbA1c levels significantly decreased from 7.1% (SD 0.6%) at baseline to 6.9% (SD 0.1%) (P=.04). Similarly, participants’ body weight decreased from 70.7 (SD 12.7) kg to 69.9 (SD 12.4) kg (P =.004) through app use. Although blood pressure decreased slightly from 128.2 (SD 12.5) mm Hg to 126.0 (SD 12.9) mm Hg, this change was not statistically significant (P=.20). Additionally, the proportion of participants engaged in ≥1 hour of daily physical activity significantly increased from 23.5% (n=4) to 58.5% (n=10) (P=.03). Conclusions: In addition to receiving standard clinical care, the use of a digital peer-supported app may significantly lower HbA1c levels in patients with T2DM by promoting healthy behaviors. 
SN  - 2561-326X
UR  - https://formative.jmir.org/2025/1/e72659
UR  - https://doi.org/10.2196/72659
DO  - 10.2196/72659
ID  - info:doi/10.2196/72659
ER  -